These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17348272

  • 1. Osteonecrosis of the jaw.
    Sykes DL.
    Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272
    [No Abstract] [Full Text] [Related]

  • 2. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.
    Marx RE.
    Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197
    [No Abstract] [Full Text] [Related]

  • 3. [Osteonecrosis of the jaw].
    Eriksen EF.
    Ugeskr Laeger; 2009 Feb 16; 171(8):629; author reply 629. PubMed ID: 19291862
    [No Abstract] [Full Text] [Related]

  • 4. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
    Aragon-Ching JB, Dahut WL.
    Oncologist; 2008 Dec 16; 13(12):1314; author reply 1315. PubMed ID: 19088325
    [No Abstract] [Full Text] [Related]

  • 5. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY, Geist JR, Aksu M.
    J Mich Dent Assoc; 2005 Nov 16; 87(11):40-2. PubMed ID: 16372547
    [No Abstract] [Full Text] [Related]

  • 6. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL.
    Gen Dent; 2007 Nov 16; 55(1):8-10. PubMed ID: 17333956
    [No Abstract] [Full Text] [Related]

  • 7. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O, Ozet A, Ataergin S, Kuzhan O, Arpaci F, Ozturk B, Komurcu S, Ozturk M.
    Oral Dis; 2007 May 16; 13(3):346-7. PubMed ID: 17448221
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
    Wynn RL.
    Gen Dent; 2005 May 16; 53(6):392-5. PubMed ID: 16366043
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM, Lawson AP, Sutphin SD, Adams VR.
    Orthopedics; 2009 Dec 16; 32(12):900. PubMed ID: 20000241
    [No Abstract] [Full Text] [Related]

  • 11. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
    Assael LA.
    J Oral Maxillofac Surg; 2007 Jul 16; 65(7):1275-6. PubMed ID: 17577488
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treating osteoporosis.
    Smith G, Stassen L, Flint S.
    Ir Med J; 2009 Mar 16; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J, George T, Sandow P, Machado M, Dickerson L, Moreb JS.
    J Support Oncol; 2009 Mar 16; 7(1):9-10. PubMed ID: 19278171
    [No Abstract] [Full Text] [Related]

  • 20. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
    Landis BN, Dojcinovic I, Richter M, Hugentobler M.
    J Intern Med; 2007 Jan 16; 261(1):101-2. PubMed ID: 17222173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.